| Product Code: ETC7538956 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
India`s CIS insulin import shipments in 2024 saw a notable shift in the top exporting countries, with Australia, USA, South Korea, Germany, and New Zealand leading the pack. The Herfindahl-Hirschman Index (HHI) indicated a significant decrease in market concentration from 2023 to 2024, moving from high to moderate concentration. The compound annual growth rate (CAGR) from 2020 to 2024 was -14.84%, reflecting a declining trend, while the growth rate for 2023 to 2024 saw a sharp decline of -48.07%. These trends suggest a dynamic and evolving landscape in the Indian CIS insulin market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India CIS Insulin Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India CIS Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 India CIS Insulin Market - Industry Life Cycle |
3.4 India CIS Insulin Market - Porter's Five Forces |
3.5 India CIS Insulin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 India CIS Insulin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 India CIS Insulin Market Revenues & Volume Share, By Source, 2021 & 2031F |
4 India CIS Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in India and CIS countries |
4.2.2 Growing awareness about diabetes management and treatment options |
4.2.3 Technological advancements in insulin delivery systems |
4.2.4 Rising healthcare expenditure in the region |
4.2.5 Favorable government initiatives and policies supporting diabetes care |
4.3 Market Restraints |
4.3.1 High cost of insulin therapy |
4.3.2 Limited access to healthcare facilities in rural areas |
4.3.3 Cultural beliefs and practices affecting diabetes management |
4.3.4 Lack of skilled healthcare professionals specialized in diabetes care |
4.3.5 Potential side effects and complications associated with insulin therapy |
5 India CIS Insulin Market Trends |
6 India CIS Insulin Market, By Types |
6.1 India CIS Insulin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 India CIS Insulin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 India CIS Insulin Market Revenues & Volume, By Type I Diabetes, 2021- 2031F |
6.1.4 India CIS Insulin Market Revenues & Volume, By Type II Diabetes, 2021- 2031F |
6.2 India CIS Insulin Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 India CIS Insulin Market Revenues & Volume, By Rapid Acting, 2021- 2031F |
6.2.3 India CIS Insulin Market Revenues & Volume, By Long Acting, 2021- 2031F |
6.2.4 India CIS Insulin Market Revenues & Volume, By Short Acting, 2021- 2031F |
6.2.5 India CIS Insulin Market Revenues & Volume, By Intermediate Acting, 2021- 2031F |
6.2.6 India CIS Insulin Market Revenues & Volume, By Premixed, 2021- 2031F |
6.3 India CIS Insulin Market, By Source |
6.3.1 Overview and Analysis |
6.3.2 India CIS Insulin Market Revenues & Volume, By Analog, 2021- 2031F |
6.3.3 India CIS Insulin Market Revenues & Volume, By Human Recombinant, 2021- 2031F |
7 India CIS Insulin Market Import-Export Trade Statistics |
7.1 India CIS Insulin Market Export to Major Countries |
7.2 India CIS Insulin Market Imports from Major Countries |
8 India CIS Insulin Market Key Performance Indicators |
8.1 Average HbA1c levels in the target population |
8.2 Adoption rate of advanced insulin delivery systems |
8.3 Number of diabetes education programs conducted in the region |
8.4 Percentage of diabetic patients regularly monitoring blood glucose levels |
8.5 Rate of complications and hospitalizations related to diabetes |
9 India CIS Insulin Market - Opportunity Assessment |
9.1 India CIS Insulin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 India CIS Insulin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 India CIS Insulin Market Opportunity Assessment, By Source, 2021 & 2031F |
10 India CIS Insulin Market - Competitive Landscape |
10.1 India CIS Insulin Market Revenue Share, By Companies, 2024 |
10.2 India CIS Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |